These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30463058)

  • 21. Targeting GRK2 and GRK5 for treating chronic degenerative diseases: Advances and future perspectives.
    Zhang Y; Zhang J; Wang J; Chen H; Ouyang L; Wang Y
    Eur J Med Chem; 2022 Dec; 243():114668. PubMed ID: 36055000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction.
    Taguchi K; Matsumoto T; Kamata K; Kobayashi T
    Endocrinology; 2012 Jul; 153(7):2985-96. PubMed ID: 22581458
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational study of paroxetine-like inhibitors reveals new molecular insight to inhibit GRK2 with selectivity over ROCK1.
    Keretsu S; Bhujbal SP; Joo Cho S
    Sci Rep; 2019 Sep; 9(1):13053. PubMed ID: 31506468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical detection, regulation and antiproliferative function of G-protein-coupled receptor kinase 2 in thyroid carcinomas.
    Métayé T; Levillain P; Kraimps JL; Perdrisot R
    J Endocrinol; 2008 Jul; 198(1):101-10. PubMed ID: 18451066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade.
    Robinson JD; Pitcher JA
    Cell Signal; 2013 Dec; 25(12):2831-9. PubMed ID: 24018045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hit-to-lead optimization and discovery of a potent, and orally bioavailable G protein coupled receptor kinase 2 (GRK2) inhibitor.
    Xu G; Gaul MD; Liu Z; DesJarlais RL; Qi J; Wang W; Krosky D; Petrounia I; Milligan CM; Hermans A; Lu HR; Huang DZ; Xu JZ; Spurlino JC
    Bioorg Med Chem Lett; 2020 Dec; 30(23):127602. PubMed ID: 33038544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance.
    Mayor F; Lucas E; Jurado-Pueyo M; Garcia-Guerra L; Nieto-Vazquez I; Vila-Bedmar R; Fernández-Veledo S; Murga C
    Arch Physiol Biochem; 2011 Jul; 117(3):125-30. PubMed ID: 21615207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietin Reverses Sepsis-Induced Vasoplegia to Norepinephrine Through Preservation of α1D-Adrenoceptor mRNA Expression and Inhibition of GRK2-Mediated Desensitization in Mouse Aorta.
    Kandasamy K; Choudhury S; Singh V; Addison MP; Darzi SA; Kasa JK; Thangamalai R; Dash JR; Kumar T; Sultan F; Singh TU; Parida S; Mishra SK
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):100-13. PubMed ID: 26025460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns.
    Lucas E; Jurado-Pueyo M; Fortuño MA; Fernández-Veledo S; Vila-Bedmar R; Jiménez-Borreguero LJ; Lazcano JJ; Gao E; Gómez-Ambrosi J; Frühbeck G; Koch WJ; Díez J; Mayor F; Murga C
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2448-56. PubMed ID: 25239306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppressed G-protein-coupled receptor kinase 2 activity protects female diabetic-mouse aorta against endothelial dysfunction.
    Taguchi K; Matsumoto T; Kamata K; Kobayashi T
    Acta Physiol (Oxf); 2013 Jan; 207(1):142-55. PubMed ID: 22925038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New roles of G protein-coupled receptor kinase 2 (GRK2) in cell migration.
    Penela P; Ribas C; Aymerich I; Mayor F
    Cell Adh Migr; 2009; 3(1):19-23. PubMed ID: 19372742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine.
    Waldschmidt HV; Homan KT; Cato MC; Cruz-Rodríguez O; Cannavo A; Wilson MW; Song J; Cheung JY; Koch WJ; Tesmer JJ; Larsen SD
    J Med Chem; 2017 Apr; 60(7):3052-3069. PubMed ID: 28323425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GRK2 at the control shaft of cellular metabolism.
    Ciccarelli M; Cipolletta E; Iaccarino G
    Curr Pharm Des; 2012; 18(2):121-7. PubMed ID: 22229580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. GRK2 as a therapeutic target for heart failure.
    Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G
    Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased nitric oxide bioavailability in adult GRK2 hemizygous mice protects against angiotensin II-induced hypertension.
    Avendaño MS; Lucas E; Jurado-Pueyo M; Martínez-Revelles S; Vila-Bedmar R; Mayor F; Salaices M; Briones AM; Murga C
    Hypertension; 2014 Feb; 63(2):369-75. PubMed ID: 24191280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. betaARKct: a therapeutic approach for improved adrenergic signaling and function in heart disease.
    Brinks H; Koch WJ
    J Cardiovasc Transl Res; 2010 Oct; 3(5):499-506. PubMed ID: 20623214
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors.
    Bouley R; Waldschmidt HV; Cato MC; Cannavo A; Song J; Cheung JY; Yao XQ; Koch WJ; Larsen SD; Tesmer JJG
    Mol Pharmacol; 2017 Dec; 92(6):707-717. PubMed ID: 29070696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Metabolic Role of GRK2 in Insulin Resistance and Associated Conditions.
    Sorriento D; Rusciano MR; Visco V; Fiordelisi A; Cerasuolo FA; Poggio P; Ciccarelli M; Iaccarino G
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.
    Gatto F; Feelders R; van der Pas R; Kros JM; Dogan F; van Koetsveld PM; van der Lelij AJ; Neggers SJ; Minuto F; de Herder W; Lamberts SW; Ferone D; Hofland LJ
    Endocrinology; 2013 Dec; 154(12):4715-25. PubMed ID: 24169548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of G-protein-coupled receptor kinase 2 (GRK2) triggers the growth-promoting mitogen-activated protein kinase (MAPK) pathway.
    Fu X; Koller S; Abd Alla J; Quitterer U
    J Biol Chem; 2013 Mar; 288(11):7738-7755. PubMed ID: 23362259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.